MARIETTA, Ga., July 31, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that its study "Biological Properties of Dehydrated Human Amnion/Chorion Grafts: Implications for Chronic Wound Healing" has been accepted for publication in the International Wound Journal. The electronic publication of the study will be available in early August, and the hard copy is expected to be published in the December 2013 edition of the International Wound Journal.
To better understand the mechanisms responsible for the healing qualities of MiMedx dehydrated amnion/chorion membrane allografts (dHACM), the MiMedx research department, led by its Chief Scientific Officer, Thomas Koob, PhD, partnered with researchers from Stanford University School of Medicine and The Georgia Institute of Technology Biotechnology Complex. Parker H. "Pete" Petit, Chairman and CEO, said, "Fundamentally, the researchers proved, among other things, that our allografts attract critically important regenerative stem cells to the wound site to help repair the wound. In effect, the research confirms that our proprietary PURION® processed allografts act as a "stem cell magnet."
Bill Taylor, President and Chief Operating Officer, stated, "The research concluded that the MiMedx dHACM allografts positively affect at least four distinct physiological processes critical to wound healing, particularly in chronic wounds. dHACM modulates the inflammatory process, inhibits metalloproteinase activity and matrix degradation, induces regenerative cell proliferation and recruits stem cells. Clearly, multiple factors work in unison to have this kind of impact. As opposed to a single therapeutic agent, dHACM allografts are a multifaceted, regenerative biomaterial that revitalizes wound healing."
"We will be submitting additional papers that delve deeper into the biological process of our 'stem cell magnet' allografts. These studies involve determining the source of the stem cells, establishing the angiogenic properties of dHACM, and gaining an in depth understanding of various mechanisms of action in wound healing," concluded Petit.